BioTech Medics Inc. Announces Development of New & Improved BioBody Balance(R) Energy Nano-Spray
September 15 2011 - 11:17AM
Marketwired
BioTech Medics Inc. (PINKSHEETS: BMCS) announced today that it has
entered into an agreement with NanoSynergy of Florida to
reformulate BioTech's existing BioBody Balance® Supplement Drink
which has sold over $5 million in gross sales into a new and
improved BioBody Balance Energy Nano-Spray for Life™.
BIOBODY BALANCE® is a new and unique 21st
Century product with over 10 years research and development. Our
demanding 24-7 lifestyle can drain the body of the physical
resources needed to meet each day's challenges. BioBody Balance
Energy Nano-Spray For Life is a caffeine-free high quality
pharmaceutical grade vitamin supplement with over 14 vitamins,
minerals, amino acids with an aloe vera base for those who are
concerned with boosting energy, alertness and general fatigue
naturally without artificial stimulants. BioBody Balance
ingredients have been clinically tested to demonstrate they help
your body restore its natural energy, strength, stamina and
defenses.
"What is unique about the 'nanosynergy' process is that the
molecular make-up of the product is reduced to molecules the size
of human red blood cells," said Keith Houser CEO. "BIOBODY BALANCE®
is superior because the product is sprayed sublingually 'under your
tongue.' Sublingual administration has certain advantages over oral
caffeine drinks because the product is absorbed faster. Being
sublingual ensures that our product will only be degraded by
salivary enzymes before entering the bloodstream."
"BioBody Balance is more economical as our suggested retail
price is less than $.83 per serving compared to a caffeine energy
drink at $2.00 or more per serving," added Mr. Houser.
The product is expected to be available by the end of this
quarter. A new web site is under development at
www.biobodybalance.net.
Safe Harbor: Forward-Looking Statements This release contains
forward-looking statements within the meaning of The Private
Securities Litigation Reform Act of 1995 (the "Act"). In
Particular, when used in the preceding discussion, the words
"expected" and similar conditional expressions are intended to
identify forward-looking statements within the meaning of the Act
and are subject to the safe harbor created by the Act. Such
statements are subject to certain risks and uncertainties and
actual results could differ materially from those expressed. The
FDA has not evaluated the BioBody Balance statements above. BioBody
Balance is not intended to diagnose, treat or cure any disease.
Contact: Tom Wood Sr. V.P. Sales Phone: 972-274-5533
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Dec 2024 to Jan 2025
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jan 2024 to Jan 2025